» » . 1/2007. 2006 |


1/2007. 2006

Synergy Research Group 123557 , . , .14
www.synrg-pharm.com

IMS Helath, 2007 , 2006 7% 643 000 000 000 . 31 , , - 2006 2075 , 7% . (I II ), III IV 95 㳿, 40 ( .. ²) 27 . 27% .

, 2006 ' 18 . , ' ( 2000 2005), 13.5 . 2007 23 (), ' 87 ' 51 . , Pfizer, J & J, GSK, Merck & Co, Eli Lilly, Abbot Labs

(, - 1 ) , , .

15 , 䳺 , . , : . - . , .. , , , , ' , , , .

, ' , , .

2007 , - , , , , , , , , , , .

ʲ

, ', . , , . ' , . ³ , , , . ʲ, ϳ , , .

, :

  • ʲ

. -, , - , , , , . , , , . ' , , , , .

-, ', , .

- , , .

, , , .

, ( 2006 ) 1428 . . - 1041 . (73%), 387 . (27%). ( 2005 ) 9500 , 16 . . - 21800 36 . . , , . ' .

, , , . - . , - . . , ... . :

  • ( ' 糠񳺿 );
  • - . - ;
  • , , ꠠ, , - , ;
  • 頠 , .

. , , '( ' ) ( , ) , , ﳿ, II . , ﳿ , , ,²- .

, , , - . , , .

' () ' . ', 糿 , . 䳿 ' 5 , .

' . : , , , , , , , . - ' : , , , .

: , . , , , ( ' ), ʲ .

5 2007 750 ' . ̳, 10 , 1.

, ̳ ' ' , .1 . -, .

1. ̳ ʲ 10

̳ , .. ʳ
1 10 1015 184
2 - 4 6694 114
3 1 4256 29
4 6132 19
5 1 2930 18
6 1 3112 17
7 -- 1 0702 15
8 1 1053 15
9 3255 14
10 8735 14
11 6448 11
12 1 0128 11
13 1 0001 11
14 1 1581 10
15 1 078 10
16 4877 10
17 6035 10
18 N /A 238
145 5130 750

2. ʳ

, . . ʳ
1 371 296
2 ϳ- 144 146
3 319 101
4 125 41
5 207 97
6 72 13
7 ϳ 217 56
1455 750

1. ʳ

2.

', . , , , ' . V. Platonov, , - .

- , , , . , , .

.. ʳ , , , . ' .

-, (, ), , , . , . , ʲ , . , :

1. ( 22.06.1998 86-)

2. 42-511-99 " "(. 29 1998)

3. ̳ ' 24 2000 . 103 " "

4. " "( 19.06.2003 266)

5. ( (.2/15) ' 11.08.2005)

6. ( (.3/17) ' 11.08.2005)

7. ' , 30.06.2004 323

" ', ". Good ClinicalPractice ICH. ʲ , FDA .

, FDA , 1996. 1995 2006 FDA 39 . 15 (No ActionIndicated, NAI), 22 , (Voluntary ActionIndicated, VAI), 2 ( -) (Official ActionIndicated, OAI). , , . , . , GCP . , - , , . , , , .

' . , . , , , . - . ' , , . , , - , , () . , 42-511-99 " ",, , GCP. ,  , .

. , (, , , ' ). IV .

-. 10 , , ʲ . 3 ( ʲ ʲ ) 2000 2007 .

3. ,

ʳ ʳ
1 GlaxoSmithKline 58 315
2 Bristol-Myers Squibb 36 250
3 Pfizer 36 113
4 Sanofi-Aventis 36 73
5 Eli Lilly and Company 34 83
6 AstraZeneca 26 110
7 Hoffmann-La Roche 21 188
8 Johnson & Johnson PharmaceuticalResearch & Development, L.L.C. 20 213
9 Novartis 16 42
10 Boehringer IngelheimPharmaceuticals 15 100
11 UCB 10 32
12 Astellas Pharma Inc 9 43
13 Bayer Corporation 7 7
14 Novo Nordisk 9 10
15 Organon 9 55
16 Solvay Pharmaceuticals 9 79
17 European Organization for Researchand Treatment of Cancer 7 8
18 Merck 7 26
19 ALTANA Pharma 6 6
20 Biogen Idec 6 40
142 914
519 2707
: www.clinicaltrials.gov

(.2), ʲ (.3).

3. ʲ 2003-2006 ( . Www.clinicaltrials.org )

4. ( . www.clinicaltrials.org )

ϳ 2006

2006 151 - 154 000 , ʲ-2006 - 846. 2006 clinicaltrials.org:

4. 2006 ʲ

ʳ ʳ ʳ
1 GlaxoSmithKline 25 118 18230
2 Sanofi-Aventis 22 22 31611
3 Bristol-MyersSquibb 10 131 32661
4 Eli Lilly andCompany 9 31 5621
5 Pfizer 7 18 6369
6 Hoffmann-LaRoche 6 87
7 AstraZeneca 5 50 19559
8 Novartis 5 13 6866
9 BoehringerIngelheim Pharmaceuticals 5 62 6793

( 4)

ʳ ʳ ʳ
10 Johnson & Johnson PharmaceuticalResearch & Development,L.L.C. 4 36 1836
11 Novo Nordisk 3 3 1941
12 Wyeth 3 7 222
13 Takeda Global Research &Development Center, Inc. 3 5 2420
14 Mannkind Corporation 3 45 1451
15 UCB 2 2 1130
16 Astellas Pharma Inc 2 11 1560
17 Merck 2 12 2522
18 ALTANA Pharma 2 2 2550
19 Bayer Corporation 1 1
20 Solvay Pharmaceuticals 1 10
31 180 10699
151 846 154041

. 3-4 . 2-3 , , , .Գ- ʲ , , . ' 2006 .

2006 507 . : 76 ,107 - ( ), 324 - . , - 49200 - 3200. . 4., ̳ 64% , , , .

5. 2006 ( ). ʲ - , ʲ - , , -

5. 2006 ( )

ʳ ʳ ʳ
I 14 618 39
II 122 7372 727
III 240 33917 2129
IV 45 4194 276
86 3140 112
507 49241 3283

6. , 2006

7. ʳ , (I-IV ) 2006

8. ʳ (I-IV ) 2006

, III .

,

(Contract Research Organization -CRO) ' 1990- , . , CRO, , , , - ' CRO .

䳺 40 , . , CRO, . , , 2004 418% . 75% - - .

, CRO CRO - CRO, ' 50% . CRO , . CRO, ' , - , -.

.

8 , .

6. , ( ).

AAIPharma CRO. ⠠1979 . - ³ (). 2006 ࠠ Cvitkovic & Associes Consultants, . . .
bioRASI 쳿 . ̳ CRO - (). 頠 . , , , -ij -.
ClinStar CRO, II-IV ⠠. - , . - . -. - 180 .
CONGENIX RO. :, , , . , , . .
Evidence Clinical andPharmaceutical Research Institute 1989 . . - 100 . - (), -, .
Hesperion ̳ CRO. ࠠ 1996 . . - . 볿,䳿, , . .
ICON Clinical CRO. ⠠1990 . I-IV.  2003 .
IN VIVO CRO. ⠠2004 쳿 젠. . Ѻ. III IV . .
INC Research ࠠ CRO, 1985 . :, , . - ⠠ (). -.

( 6)

Kendle CRO.- (). 3000 .³ .
LEGE ARTIS ࠠ . . ຠ , , I-IV.
Matrix PharmaceuticalResearch CRO. II-IV . 頠 .
Omnicare CRO, I-IV.- (). CRO (ACRO). .
Osmos 2004 . , 𠠠, . - ⠠ ().
Outsourcing Clinical Trials(OCT) CRO 젠 -. , , , ࠠ . 2006 .
Parexel CRO. ⠠1983 . 5000 35 . .- . (). .
Pharmanet CRO, . 1996 . - 1200 . -.
Pharm-Olam International CRO. ⠠1994 . 40 . . ᠠ ' (). .
PRA International CRO. ⠠1981 . - 2700 . .- (). .
Premier Research 1998 . , 30 . : , , . - Գ (). .

( 6)

PSI RO . . - 堠600 . - - .
RCT-Global CRO, . 2001 . . -ࠠ (). .
SynergyResearch Group CRO. 2002 . . - 50 . .  -, , .
IJ


...


1 (0,02765)